TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial.

Michiko Asano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.